Solid Biosciences Inc. ($SLDB)
Filing Information
| Accession Number | 0001193125-26-034085 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 3, 2026 |
| Document Date | Jan 29, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
476,635
Total Value
$170,803.14
P&L
+inf% (+$2,029,200.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Regulatory Officer | Common Stock | โ | Jan 29, 2026 | Exercise/Conversion | 54,925 | โ | โ | 81,585 | Direct | โ | View Details | |
Chief Regulatory Officer | Common Stock | โ | Jan 31, 2026 | Exercise/Conversion | 27,625 | โ | โ | 109,210 | Direct | โ | View Details | |
Chief Regulatory Officer | Common Stock | โ | Feb 2, 2026 | Sale | 26,535 | $6.44 | $170,803.14 | 82,675 | Direct | โ | View Details | |
Chief Regulatory Officer | Performance Stock Units | Derivative | Jan 29, 2026 | Exercise/Conversion | 54,925 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Regulatory Officer | Employee Stock Option (Right to Buy) | Derivative | Jan 29, 2026 | Grant/Award | 190,000 | $0.00 | $0.00 | 190,000 | Direct | โ | View Details | |
Chief Regulatory Officer | Restricted Stock Units | Derivative | Jan 29, 2026 | Grant/Award | 95,000 | $0.00 | $0.00 | 95,000 | Direct | โ | View Details | |
Chief Regulatory Officer | Restricted Stock Units | Derivative | Jan 31, 2026 | Exercise/Conversion | 27,625 | $0.00 | $0.00 | 82,875 | Direct | โ | View Details |